» Authors » Panagiota-Christina Georgiou

Panagiota-Christina Georgiou

Explore the profile of Panagiota-Christina Georgiou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 78
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Meletiadis J, Siopi M, Spruijtenburg B, Georgiou P, Kostoula M, Vourli S, et al.
Euro Surveill . 2024 Nov; 29(45). PMID: 39512169
After the start of the COVID-19 pandemic, a rapid rise in reported numbers and wide geographic spread of -related invasive infections has been observed globally. However, the contemporary epidemiology of...
2.
Siopi M, Georgiou P, Paranos P, Beredaki M, Tarpatzi A, Kalogeropoulou E, et al.
Euro Surveill . 2024 Jul; 29(29). PMID: 39027938
BackgroundThe COVID-19 pandemic and the emergence of have changed the epidemiological landscape of candidaemia worldwide.AimWe compared the epidemiological trends of candidaemia in a Greek tertiary academic hospital before (2009-2018) and...
3.
Vasilakopoulou A, Naas T, Gonzalez C, Vila J, Szabo D, Riccobono E, et al.
JAC Antimicrob Resist . 2024 Mar; 6(2):dlae029. PMID: 38455379
Objectives: A multicentre study evaluating NG-Test DetecTool OXA-23 for the detection of OXA-23 carbapenemase directly from positive blood cultures (PBCs). Methods: The NG-Test DetecTool OXA-23 is an immunoassay that integrates...
4.
Siopi M, Georgiou P, Pournaras S, Meletiadis J
J Antimicrob Chemother . 2023 Oct; 78(12):2830-2839. PMID: 37811550
Background: Because of the high inoculum (105 cfu/mL) used in the EUCAST susceptibility testing of Aspergillus spp., determination of the minimal effective concentration (MEC) of echinocandins is challenging as the...
5.
Siopi M, Antonopoulou S, Mantzana P, Georgiou P, Vourli S, Protonotariou E, et al.
Med Mycol . 2022 Dec; 61(1). PMID: 36477291
Aspergillus spp. isolated from non-BAL cultures of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) patients may reflect colonization rather than infection. Sera (n = 181) from 49 adult ICU CAPA...
6.
Georgiou P, Arendrup M, Meletiadis J
J Antimicrob Chemother . 2022 Mar; 77(6):1655-1661. PMID: 35323941
Background: Increased fluconazole and echinocandin resistance in Candida glabrata requires prompt detection in routine settings. A phenotypic test based on the EUCAST E.DEF 7.3.2 protocol was developed for the detection...
7.
Meletiadis J, Paranos P, Georgiou P, Vourli S, Antonopoulou S, Michelaki A, et al.
Int J Antimicrob Agents . 2021 Sep; 58(5):106440. PMID: 34551356
Metallo-beta-lactamase (MBL)-producing Gram-negative bacteria are increasing worldwide and very few agents are active against these pathogens. Taniborbactam (formerly VNRX-5133) is a newly developed bicyclic boronate beta-lactamase inhibitor that directly inhibits...
8.
Kloezen W, Melchers R, Georgiou P, Mouton J, Meletiadis J
Antimicrob Agents Chemother . 2021 Jan; 65(4). PMID: 33431413
Extended-spectrum-β-lactamase (ESBL)-producing strains are increasing worldwide, limiting therapeutic options. Taniborbactam (VNRX-5133) is a newly developed β-lactamase inhibitor with a wide spectrum of activity covering both serine and metallo enzymes. We...
9.
Beredaki M, Georgiou P, Siopi M, Kanioura L, Andes D, Arendrup M, et al.
Antimicrob Agents Chemother . 2020 Apr; 64(6). PMID: 32229492
CLSI and EUCAST susceptibility breakpoints for voriconazole and differ by one dilution (≤0.125 and ≤0.06 mg/liter, respectively) whereas the epidemiological cutoff values for EUCAST (ECOFF) and CLSI (ECV) are the...
10.
Georgiou P, Mouton J, Pournaras S, Meletiadis J
J Med Microbiol . 2020 Apr; 69(5):676-684. PMID: 32228800
Quantification of bacterial load in tissue homogenates in pharmacodynamic studies is cumbersome and time-consuming. We therefore developed a new method for quantifying bacterial load in tissue homogenates of animals treated...